Startseite › Brustkrebs › North Carolina › Durham
Klinische Studien zu Brustkrebs in Durham, NC
64 Studien zu Brustkrebs suchen Teilnehmer an Standorten in und um Durham (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
The Vanguard Study: Testing a New Way to Screen for Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
A Study of PHST001 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Teilnehmer gesuchtPhase 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Teilnehmer gesuchtPhase 2Gesunde Freiwillige willkommen
- University of North Carolina, Chapel Hill · 10 mi entfernt
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- University of North Carolina, Chapel Hill · 10 mi entfernt
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Teilnehmer gesuchtPhase 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Teilnehmer gesuchtPhase 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi entfernt
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Teilnehmer gesuchtPhase 2
- University of North Carolina Medical Center, Chapel Hill · 10 mi entfernt
Identifying Patterns in the Breath of Individuals With Breast Cancer
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Teilnehmer gesuchtPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi entfernt
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Teilnehmer gesuchtPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi entfernt
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Teilnehmer gesuchtPhase 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Teilnehmer gesuchtBeobachtungsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Teilnehmer gesuchtPhase 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Teilnehmer gesuchtPhase 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Teilnehmer gesuchtPhase 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Teilnehmer gesuchtPhase 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Teilnehmer gesuchtPhase 2
- University of North Carolina, Chapel Hill · 10 mi entfernt
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Teilnehmer gesuchtPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi entfernt
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Teilnehmer gesuchtPhase 2
- University of North Carolina, Chapel Hill · 10 mi entfernt
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Teilnehmer gesucht
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
Teilnehmer gesuchtBeobachtungsstudie
- University of North Carolina, Chapel Hill · 10 mi entfernt
Weight Management After Cancer for Survivors in Rural Communities
Teilnehmer gesucht
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Teilnehmer gesucht
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Teilnehmer gesuchtPhase 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Teilnehmer gesucht
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Teilnehmer gesuchtPhase 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Teilnehmer gesucht
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Teilnehmer gesuchtPhase 1
- University of North Carolina, Chapel Hill · 10 mi entfernt
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Teilnehmer gesucht
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi entfernt
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Teilnehmer gesucht
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Teilnehmer gesuchtBeobachtungsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi entfernt
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Teilnehmer gesuchtPhase 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Teilnehmer gesuchtPhase 1
- University of North Carolina, Chapel Hill · 10 mi entfernt
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Teilnehmer gesuchtPhase 2Gesunde Freiwillige willkommen
- The University of North Carolina, Chapel Hill · 10 mi entfernt
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Teilnehmer gesuchtBeobachtungsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Teilnehmer gesuchtPhase 2
- University of North Carolina, Chapel Hill · 10 mi entfernt
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Teilnehmer gesucht
- University of North Carolina, Chapel Hill · 10 mi entfernt
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Teilnehmer gesuchtPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi entfernt
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Teilnehmer gesuchtPhase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Teilnehmer gesuchtPhase 2
- University of North Carolina, Chapel Hill · 10 mi entfernt
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Teilnehmer gesuchtPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Teilnehmer gesucht
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Teilnehmer gesuchtPhase 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Teilnehmer gesuchtBeobachtungsstudie
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- University of North Carolina, Chapel Hill · 10 mi entfernt
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Teilnehmer gesucht
- UNC Cancer Hospital, Chapel Hill · 10 mi entfernt
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Teilnehmer gesucht
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Teilnehmer gesucht
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Teilnehmer gesucht
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mi entfernt
BREAST Choice Decision Tool R21 - AIM2
Teilnehmer gesuchtGesunde Freiwillige willkommen
- The University of North Carolina, Chapel Hill · 10 mi entfernt
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Teilnehmer gesucht
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi entfernt
UNC Pleural Fluid Registry
Teilnehmer gesuchtBeobachtungsstudie
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi entfernt
Brustkrebs-Studien in anderen Städten
- New York City, NY136 Studien
- Houston, TX126 Studien
- Boston, MA112 Studien
- Nashville, TN81 Studien
- Los Angeles, CA73 Studien
- Edison, NJ68 Studien
- St. Louis, MO64 Studien
- Queens, NY64 Studien
- Chicago, IL59 Studien
- Philadelphia, PA56 Studien
- Dallas, TX55 Studien
- Arlington, VA47 Studien
Weitere Studien in Durham
- Krebs (alle Arten)58 Studien
- Nichtkleinzelliges Lungenkarzinom39 Studien
- Multiples Myelom37 Studien
- Akute myeloische Leukämie33 Studien
- Metastasierender Krebs33 Studien
- Prostatakrebs32 Studien
- Lungenkrebs32 Studien
- Kolorektales Karzinom28 Studien
- Eierstockkrebs27 Studien
- Chronische lymphatische Leukämie27 Studien
- Herzinsuffizienz26 Studien
- Bauchspeicheldrüsenkrebs24 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.